BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27450174)

  • 1. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL; Ibáñez Camacho MF; López Pérez E
    Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dual agranulocytosis episode likely resulting from metamizole use].
    Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
    Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Agranulocytosis in a patient treated with metamizole and clopidogrel].
    Kummer O; Haschke M; Tuchscherer D; Lampert M; Martius F; Krähenbühl S
    Praxis (Bern 1994); 2006 Nov; 95(45):1743-5; quiz 1746-7. PubMed ID: 17205929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methamizole-induced agranulocytosis].
    Pedrazas López D; de Pablo Márquez B; García Font D; Sánchez García E
    Med Clin (Barc); 2016 Apr; 146(7):e41. PubMed ID: 26602309
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J
    South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure and severe thrombocytopenia associated with metamizole.
    Redondo-Pachon MD; Enriquez R; Sirvent AE; Millan I; Romero A; Amorós F
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):121-5. PubMed ID: 24434395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis].
    Send T; Westermann S; Eichhorn KW; Jakob M
    HNO; 2015 Mar; 63(3):215-9. PubMed ID: 25515122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agranulocytosis from metamizole: a potential problem for the British population].
    Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
    Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyrone and agranulocytosis: what is the risk?
    Edwards JE; McQuay HJ
    Lancet; 2002 Nov; 360(9344):1438. PubMed ID: 12433507
    [No Abstract]   [Full Text] [Related]  

  • 17. Advise against metamizole.
    Neumann J
    Dtsch Arztebl Int; 2009 Jan; 106(4):55-6; author reply 56. PubMed ID: 19564968
    [No Abstract]   [Full Text] [Related]  

  • 18. Dipyrone and agranulocytosis: what is the risk?
    Schönhöfer P; Offerhaus L; Herxheimer A
    Lancet; 2003 Mar; 361(9361):968-9. PubMed ID: 12648993
    [No Abstract]   [Full Text] [Related]  

  • 19. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.